Postmenopausal hormone use and symptoms of gastroesophageal reflux

Archives of Internal Medicine

Volumn 168, Issue 16, 2008, Pages 1798-1804

  Jacobson, Brian C ^a,f   Moy, Beverly ^b,c   Colditz, Graham A ^e   Fuchs, Charles S ^c,d  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d DANA FARBER CANCER INSTITUTE   (United States)

^e WASHINGTON UNIVERSITY   (United States)

^f BOSTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; PROGESTERONE;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; FEMALE; GASTROESOPHAGEAL REFLUX; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; RISK ASSESSMENT;

ADULT; BODY MASS INDEX; DRUGS, NON-PRESCRIPTION; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; MIDDLE AGED; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SELECTIVE ESTROGEN RECEPTOR MODULATORS;

EID: 51649083817     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.168.16.1798     Document Type: Article

References (30)

1. El-Serag HB, Petersen N, Carter J, et al. Gastroesophageal reflux among different racial groups in the United States. Gastroenterology. 2004;126(7):1692-1699.
2. Locke GR, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology. 1997;112(5):1448-1456.
3. Klauser AG, Schindlbeck N, Muller-Lissner SA. Symptoms in gastrooesophageal reflux disease. Lancet. 1990;335(8683):205-208.
4. Sandler RS, Everhart J, Donowitz M, et al. The burden of selected digestive diseases in the United States. Gastroenterology. 2002;122(5):1500-1511.
5. Van Thiel DH, Gavaler J, Hoshi S, Sara R, Stremple J. Heartburn of pregnancy. Gastroenterology. 1977;72(4, pt 1):666-668.
6. Van Thiel DH, Gavaler J, Stremple J. Lower esophageal sphincter pressure in women using sequential oral contraceptives. Gastroenterology. 1976;71(2):232-234.
7. Schulze K, Christensen J. Lower sphincter of the opossum esophagus in pseudopregnancy. Gastroenterology. 1977;73(5):1082-1085.
8. Fisher RS, Roberts G, Grabowski C, Cohen S. Altered lower esophageal sphincter function during early pregnancy. Gastroenterology. 1978;74(6):1233-1237.
9. Fisher RS, Roberts G, Grabowski C, Cohen S. Inhibition of lower esophageal sphincter circular muscle by female sex hormones. Am J Physiol. 1978;234(3):E243-E247.
10. Nilsson M, Lundegardh G, Carling L, Ye W, Lagergren J. Body mass and reflux esophagitis: an oestrogen-dependent association? Scand J Gastroenterol. 2002;37(6):626-630.
11. Nilsson M, Johnsen R, Ye W, Hveem K, Lagergren J. Obesity and estrogen as risk factors for gastroesophageal reflux symptoms. JAMA. 2003;290(1):66-72.
12. Rimm EB, Stampfer MJ, Colditz GA, Chute CG, Litin LB, Willett WC. Validity of self-reported waist and hip circumferences in men and women. Epidemiology. 1990;1(6):466-473.
13. Wolf AM, Hunter DJ, Colditz GA, et al. Reproducibility and validity of a self-administered physical activity questionnaire. Int J Epidemiol. 1994;23(5):991-999.
14. Willett WC, Sampson L, Stampfer MJ, et al. Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol. 1985;122(1):51-65.
15. Riggs BL, Hartmann LC. Selective estrogen-receptor modulators: mechanism of action and application to clinical practice. N Engl J Med. 2003;348(7):618-629.
16. Barrett-Connor E, Mosca L, Collins P, et al. Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women. N Engl J Med. 2006;355(2):125-137.
17. Nedrow A, Miller J, Walker M, Nygren P, Huffman LH, Nelson HD. Complementary and alternative therapies for the management of menopause-related symptoms: a systematic evidence review. Arch Intern Med. 2006;166(14):1453-1465.
18. Kronenberg F, Fugh-Berman A. Complementary and alternative medicine for menopausal symptoms: a review of randomized, controlled trials. Ann Intern Med. 2002;137(10):805-813.
19. Jacobson BC, Somers SC, Fuchs CS, Kelly CP, Camargo CA Jr. Body-mass index and symptoms of gastroesophageal reflux in women. N Engl J Med. 2006;354(22):2340-2348.
20. Best PJM, Berger PB, Miller VM, Lerman A. The effect of estrogen replacement therapy on plasma nitric oxide and endothelin-1 levels in postmenopausal women. Ann Intern Med. 1998;128(4):285-288.
21. Mittal RK, Balaban DH. The esophagogastric junction. N Engl J Med. 1997;336(13):924-932.
22. Hirsch DP, Holloway RH, Tytgat GNJ, Boeckxstaens GEE. Involvement of nitric oxide in human transient lower esophageal sphincter relaxations and esophageal primary peristalsis. Gastroenterology. 1998;115(6):1374-1380.
23. Dent J, Dodds WJ, Friedman RH, et al. Mechanism of gastroesophageal reflux in recumbent asymptomatic human subjects. J Clin Invest. 1980;65(2):256-267.
24. Dodds WJ, Dent J, Hogan WJ, et al. Mechanisms of gastroesophageal reflux in patients with reflux esophagitis. N Engl J Med. 1982;307(25):1547- 1552.
25. Jokela H, Dastidar P, Rontu R, et al. Effects of long-term estrogen replacement therapy versus combined hormone replacement therapy on nitric oxide-dependent vasomotor function. J Clin Endocrinol Metab. 2003;88(9):4348-4354.
26. Locke GR, Talley NJ, Weaver AL, Zinsmeister AR. A new questionnaire for gastroesophageal reflux disease. Mayo Clin Proc. 1994;69(6):539-547.
27. Locke GR, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ. Risk factors associated with symptoms of gastroesophageal reflux. Am J Med. 1999;106(6):642-649.
28. El-Serag HB, Graham D, Satia J, Rabeneck L. Obesity is an independent risk factor for GERD symptoms and erosive esophagitis. Am J Gastroenterol. 2005;100(6):1243-1250.
29. Johnson DA, Fennerty MB. Heartburn severity underestimates erosive esophagitis severity in elderly patients with gastroesophageal reflux disease. Gastroenterology. 2004;126(3):660-664.
30. Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med. 1999;340(11):825-831.